{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:51:19Z","timestamp":1780462279340,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211100\/Z\/18\/Z"],"award-info":[{"award-number":["211100\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>To examine the use of positron emission tomography (PET) for imaging post-infarct myocardial inflammation and repair.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>Dysregulated immune responses after myocardial infarction are associated with adverse cardiac remodelling and an increased likelihood of ischaemic heart failure. PET imaging utilising novel tracers can be applied to visualise different components of the post-infarction inflammatory and repair processes. This approach could offer unique pathophysiological insights that could prove useful for the identification and risk-stratification of individuals who would ultimately benefit most from emerging immune-modulating therapies. PET imaging could also bridge the clinical translational gap as a surrogate measure of drug efficacy in early-stage clinical trials in patients with myocardial infarction. The use of hybrid PET\/MR imaging, in particular, offers the additional advantage of simultaneous in vivo molecular imaging and detailed assessment of myocardial function, viability and tissue characterisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Further research is needed to realise the true clinical translational value of PET imaging after myocardial infarction.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11886-021-01529-9","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:03:20Z","timestamp":1625130200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["PET Imaging of Post-infarct Myocardial Inflammation"],"prefix":"10.1007","volume":"23","author":[{"given":"Andrej","family":"\u0106orovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Nus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H. F.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-120X","authenticated-orcid":false,"given":"Jason M.","family":"Tarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"1529_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"1529_CR2","doi-asserted-by":"crossref","unstructured":"Adamo L,\u00a0Rocha-Resende C,\u00a0Prabhu SD,\u00a0Mann DL. Reappraising the role of inflammation in heart failure. Nat\u00a0Rev Cardiol.\u00a02020;17(5):269\u201385.","DOI":"10.1038\/s41569-019-0315-x"},{"key":"1529_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med"},{"key":"1529_CR4","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif J-C, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497\u2013505.","journal-title":"N Engl J Med"},{"key":"1529_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"\u2022\u2022 Everett BM, Cornel J, Lainscak M, Anker SD, Abbate A, Thuren T, et al. Anti-Inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation. 2019;139:1289\u201399 In patients with prior myocardial infarction and elevated high-sensitivity CRP treated with the interleukin-1\u03b2 monoclonal antibody canakinumab, there was a dose-dependent reduction in hospitalisation for heart failure and the composite end-point of hospitalisation for heart failure or heart failure-related mortality.","journal-title":"Circulation."},{"key":"1529_CR6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in heart failure JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:1324\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR7","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","volume":"121","author":"M Nahrendorf","year":"2010","unstructured":"Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121:2437\u201345.","journal-title":"Circulation."},{"key":"1529_CR8","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman PC, Lipinski MJ, Luger D, Waksman R, Bonow RO, Wu E, et al. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2016;67:2050\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yjmcc.2013.05.017","volume":"62","author":"MA Ismahil","year":"2013","unstructured":"Ismahil MA, Prabhu SD. Cardiac immune cell remodeling after myocardial infarction. J Mol Cell Cardiol. 2013;62:142\u20133.","journal-title":"J Mol Cell Cardiol"},{"key":"1529_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","volume":"96","author":"O Dewald","year":"2005","unstructured":"Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, et al. CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881\u20139.","journal-title":"Circ Res"},{"key":"1529_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612\u20136.","journal-title":"Science."},{"key":"1529_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather J, Hofmann UDW, Beyersdorf N, Ramos GC, Vogel B, Frey A, et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ Res. 2014;115:55\u201367.","journal-title":"Circ Res"},{"key":"1529_CR13","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037\u201347.","journal-title":"J Exp Med"},{"key":"1529_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurheartj\/eht331","volume":"35","author":"AM van der Laan","year":"2014","unstructured":"van der Laan AM, ter Horst EN, Delewi R, Begieneman MPV, Krijnen PAJ, Hirsch A, et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35:376\u201385.","journal-title":"Eur Heart J"},{"key":"1529_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jacc.2009.04.021","volume":"54","author":"H Tsujioka","year":"2009","unstructured":"Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54:130\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCHEARTFAILURE.108.827071","volume":"2","author":"G Engstr\u00f6m","year":"2009","unstructured":"Engstr\u00f6m G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail. 2009;2:217\u201322.","journal-title":"Circ Heart Fail"},{"key":"1529_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Gu\u00e9rin C, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19:1273\u201380.","journal-title":"Nat Med"},{"key":"1529_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","volume":"119","author":"HB Sager","year":"2016","unstructured":"Sager HB, Hulsmans M, Lavine KJ, Moreira MB, Heidt T, Courties G, et al. Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure. Circ Res. 2016;119:853\u201364.","journal-title":"Circ Res"},{"key":"1529_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","volume":"127","author":"MD Majmudar","year":"2013","unstructured":"Majmudar MD, Keliher EJ, Heidt T, Leuschner F, Truelove J, Sena BF, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation. 2013;127:2038\u201346.","journal-title":"Circulation."},{"key":"1529_CR20","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.110.227454","volume":"107","author":"F Leuschner","year":"2010","unstructured":"Leuschner F, Panizzi P, Chico-Calero I, Lee WW, Ueno T, Cortez-Retamozo V, et al. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res. 2010;107:1364\u201373.","journal-title":"Circ Res"},{"key":"1529_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCRESAHA.117.311071","volume":"122","author":"L Honold","year":"2018","unstructured":"Honold L, Nahrendorf M. Resident and monocyte-derived macrophages in cardiovascular disease. Circ Res. 2018;122:113\u201327.","journal-title":"Circ Res"},{"key":"1529_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol. 2019;20:29\u201339.","journal-title":"Nat Immunol"},{"key":"1529_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 2018;24:1234\u201345.","journal-title":"Nat Med"},{"key":"1529_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","volume":"124","author":"G Bajpai","year":"2019","unstructured":"Bajpai G, Bredemeyer A, Li W, Zaitsev K, Koenig AL, Lokshina I, et al. Tissue resident CCR2\u2212 and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ Res. 2019;124:263\u201378.","journal-title":"Circ Res"},{"key":"1529_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jacc.2013.11.023","volume":"63","author":"G Courties","year":"2014","unstructured":"Courties G, Heidt T, Sebas M, Iwamoto Y, Jeon D, Truelove J, et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol. 2014;63:1556\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR26","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","volume":"104","author":"P Krishnamurthy","year":"2009","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009;104:e9\u201318.","journal-title":"Circ Res"},{"key":"1529_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.116.309194","volume":"119","author":"M Nahrendorf","year":"2016","unstructured":"Nahrendorf M, Swirski FK. Abandoning M1\/M2 for a network model of macrophage function. Circ Res. 2016;119:414\u20137.","journal-title":"Circ Res"},{"key":"1529_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","volume":"116","author":"C Peet","year":"2019","unstructured":"Peet C, Ivetic A, Bromage DI, Shah AM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2019;116:1101\u201312.","journal-title":"Cardiovasc Res"},{"key":"1529_CR29","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1093\/eurheartj\/ehx581","volume":"39","author":"RM Hoogeveen","year":"2017","unstructured":"Hoogeveen RM, Nahrendorf M, Riksen NP, Netea MG, de Winther MPJ, Lutgens E, et al. Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases. Eur Heart J. 2017;39:3521\u20137.","journal-title":"Eur Heart J"},{"key":"1529_CR30","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301198","volume":"113","author":"E Wan","year":"2013","unstructured":"Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. 2013;113:1004\u201312.","journal-title":"Circ Res"},{"key":"1529_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jacc.2011.08.066","volume":"59","author":"WW Lee","year":"2012","unstructured":"Lee WW, Marinelli B, van der Laan AM, Sena BF, Gorbatov R, Leuschner F, et al. PET\/MRI of inflammation in myocardial infarction. J Am Coll Cardiol. 2012;59:153\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/CIRCIMAGING.114.001689","volume":"7","author":"T Wollenweber","year":"2014","unstructured":"Wollenweber T, Roentgen P, Sch\u00e4fer A, Schatka I, Zwadlo C, Brunkhorst T, et al. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging. Circ Cardiovasc Imaging. 2014;7:811\u20138.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1529_CR33","doi-asserted-by":"publisher","first-page":"e004316","DOI":"10.1161\/CIRCIMAGING.115.004316","volume":"9","author":"C Rischpler","year":"2016","unstructured":"\u2022 Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, et al. Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography\/magnetic resonance imaging as a prognostic marker of functional outcome. Circ Cardiovasc Imaging. 2016;9:e004316 A prospective study that compared post-infarct PET inflammatory signals with longitudinal assessment of LV function. 18F-FDG uptake in the first week after myocardial infarction was shown to be associated with an increased likelihood of left ventricular impairment on MRI after 6 months, independent of infarct size.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1529_CR34","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","volume":"73","author":"JM Tarkin","year":"2019","unstructured":"Tarkin JM, Calcagno C, Dweck MR, Evans NR, Chowdhury MM, Gopalan D, et al. 68Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction. J Am Coll Cardiol. 2019;73:2489\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR35","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jcmg.2015.09.007","volume":"8","author":"C Lapa","year":"2015","unstructured":"Lapa C, Reiter T, Werner RA, Ertl G, Wester H-J, Buck AK, et al. [68Ga]Pentixafor-PET\/CT for imaging of chemokine receptor 4 expression after myocardial infarction. JACC Cardiovasc Imaging. 2015;8:1466\u20138.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1529_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/heartjnl-2016-310115","volume":"103","author":"WSA Jenkins","year":"2016","unstructured":"\u2022 Jenkins WSA, Vesey AT, Stirrat C, Connell M, Lucatelli C, Neale A, et al. Cardiac \u03b1 V \u03b2 3 integrin expression following acute myocardial infarction in humans. Heart. 2016;103:607\u201315 This clinical study highlighted the role of \u2018reparative\u2019 processes such as neoangiogenesis in predicting the likelihood of longer term left ventricular recovery.","journal-title":"Heart"},{"key":"1529_CR37","doi-asserted-by":"publisher","unstructured":"Siebermair J, K\u00f6hler MI, Kupusovic J, Nekolla SG, Kessler L, Ferdinandus J, et al. Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling. J Nucl Cardiol. 2020. https:\/\/doi.org\/10.1007\/s12350-020-02307-w.","DOI":"10.1007\/s12350-020-02307-w"},{"key":"1529_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","volume":"71","author":"JT Thackeray","year":"2018","unstructured":"\u2022 Thackeray JT, Hupe HC, Wang Y, Bankstahl JP, Berding G, Ross TL, et al. Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J Am Coll Cardiol. 2018;71:263\u201375 Early increases in TSPO PET signals after myocardial infarction in mice were predictive of subsequent adverse left ventricular remodelling at 8 weeks. Treatment with angiotensin-converting enzyme inhibitor reduced the TSPO signal. Interestingly, changes in neuroinflammation as detected by the TSPO PET occurred in parallel to myocardial signal changes.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","volume":"194","author":"C Lapa","year":"2015","unstructured":"Lapa C, Reiter T, Li X, Werner RA, Samnick S, Jahns R, et al. Imaging of myocardial inflammation with somatostatin receptor based PET\/CT \u2014 a comparison to cardiac MRI. Int J Cardiol. 2015;194:44\u20139.","journal-title":"Int J Cardiol"},{"key":"1529_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","volume":"8","author":"JT Thackeray","year":"2015","unstructured":"Thackeray JT, Derlin T, Haghikia A, Napp LC, Wang Y, Ross TL, et al. Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc Imaging. 2015;8:1417\u201326.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1529_CR41","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jcmg.2018.01.001","volume":"11","author":"T Reiter","year":"2018","unstructured":"Reiter T, Kircher M, Schirbel A, Werner RA, Kropf S, Ertl G, et al. Imaging of C-X-C motif chemokine receptor CXCR4 expression after myocardial infarction with [68Ga]Pentixafor-PET\/CT in correlation with cardiac MRI. JACC Cardiovasc Imaging. 2018;11:1541\u20133.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1529_CR42","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","volume":"41","author":"A Hess","year":"2020","unstructured":"\u2022 Hess A, Derlin T, Koenig T, Diekmann J, Wittneben A, Wang Y, et al. Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. Eur Heart J. 2020;41:3564\u201375 The incidence of left ventricular rupture in mice after MI was reduced by administration of a CXCR4 blocking agent within the first 3 days post-infarct. In 50 patients, infarct-related CXCR4 signals were inversely correlated with left ventricular function.","journal-title":"Eur Heart J"},{"key":"1529_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2967\/jnumed.120.244673","volume":"62","author":"GS Heo","year":"2020","unstructured":"Heo GS, Bajpai G, Li W, Luehmann HP, Sultan DH, Dun H, et al. Targeted PET imaging of chemokine receptor 2\u2013positive monocytes and macrophages in the injured heart. J Nucl Med. 2020;62:111\u20134.","journal-title":"J Nucl Med"},{"key":"1529_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","volume":"124","author":"GS Heo","year":"2019","unstructured":"Heo GS, Kopecky B, Sultan D, Ou M, Feng G, Bajpai G, et al. Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart. Circ Res. 2019;124:881\u201390.","journal-title":"Circ Res"},{"key":"1529_CR45","doi-asserted-by":"publisher","first-page":"e010586","DOI":"10.1161\/CIRCIMAGING.120.010586","volume":"13","author":"M Nahrendorf","year":"2020","unstructured":"\u2022 Nahrendorf M, Hoyer FF, Meerwaldt AE, van Leent MMT, Senders ML, Calcagno C, et al. Imaging Cardiovascular and lung macrophages with the positron emission tomography sensor 64 Cu-Macrin in mice, rabbits, and pigs. Circ Cardiovasc Imaging. 2020;13:e010586 In this preclinical study, 64Cu-Macrin was shown to be taken up by macrophages within infarcted myocardium, with negligible uptake by neutrophils, fibroblasts and endothelial cells.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1529_CR46","doi-asserted-by":"publisher","first-page":"14064","DOI":"10.1038\/ncomms14064","volume":"8","author":"EJ Keliher","year":"2017","unstructured":"Keliher EJ, Ye Y-X, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, et al. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nat Commun. 2017;8:14064.","journal-title":"Nat Commun"},{"key":"1529_CR47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2967\/jnumed.108.061341","volume":"50","author":"M Morooka","year":"2009","unstructured":"Morooka M, Kubota K, Kadowaki H, Ito K, Okazaki O, Kashida M, et al. 11C-Methionine PET of acute myocardial infarction. J Nucl Med. 2009;50:1283\u20137.","journal-title":"J Nucl Med"},{"key":"1529_CR48","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.7150\/thno.15929","volume":"6","author":"JT Thackeray","year":"2016","unstructured":"Thackeray JT, Bankstahl JP, Wang Y, Wollert KC, Bengel FM. Targeting amino acid metabolism for molecular imaging of inflammation early after myocardial infarction. Theranostics. 2016;6:1768\u201379.","journal-title":"Theranostics."},{"key":"1529_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2967\/jnumed.112.112060","volume":"54","author":"J Taki","year":"2013","unstructured":"Taki J, Wakabayashi H, Inaki A, Imanaka-Yoshida K, Hiroe M, Ogawa K, et al. 14C-methionine uptake as a potential marker of inflammatory processes after myocardial ischemia and reperfusion. J Nucl Med. 2013;54:431\u20136.","journal-title":"J Nucl Med"},{"key":"1529_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/cvr\/cvn033","volume":"78","author":"T Higuchi","year":"2008","unstructured":"Higuchi T, Bengel FM, Seidl S, Watzlowik P, Kessler H, Hegenloh R, et al. Assessment of \u03b1v\u03b23 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res. 2008;78:395\u2013403.","journal-title":"Cardiovasc Res"},{"key":"1529_CR51","doi-asserted-by":"publisher","first-page":"778","DOI":"10.7150\/thno.8809","volume":"4","author":"Y Sun","year":"2014","unstructured":"Sun Y, Zeng Y, Zhu Y, Feng F, Xu W, Wu C, et al. Application of68Ga-PRGD2 PET\/CT for \u03b1v\u03b23-integrin imaging of myocardial infarction and stroke. Theranostics. 2014;4:778\u201386.","journal-title":"Theranostics."},{"key":"1529_CR52","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","volume":"60","author":"Z Varasteh","year":"2019","unstructured":"Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, et al. Molecular imaging of fibroblast activity after myocardial infarction using a 68 Ga-labeled fibroblast activation protein inhibitor, FAPI-04. J Nucl Med. 2019;60:1743\u20139.","journal-title":"J Nucl Med"},{"key":"1529_CR53","doi-asserted-by":"publisher","first-page":"e010628","DOI":"10.1161\/CIRCIMAGING.120.010628","volume":"13","author":"MB Heckmann","year":"2020","unstructured":"Heckmann MB, Reinhardt F, Finke D, Katus HA, Haberkorn U, Leuschner F, et al. Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease. Circ Cardiovasc Imaging. 2020;13:e010628.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1529_CR54","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s10495-018-1463-x","volume":"23","author":"H Ma","year":"2018","unstructured":"Ma H, Liu S, Xiong Y, Zhang Z, Sun A, Su S, et al. PET imaging of cardiomyocyte apoptosis in a rat myocardial infarction model. Apoptosis. 2018;23:396\u2013407.","journal-title":"Apoptosis."},{"key":"1529_CR55","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s12350-017-0918-8","volume":"25","author":"S Marchesseau","year":"2018","unstructured":"Marchesseau S, Seneviratna A, Sj\u00f6holm AT, Qin DL, Ho JXM, Hausenloy DJ, et al. Hybrid PET\/CT and PET\/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction. J Nucl Cardiol. 2018;25:2001\u201311.","journal-title":"J Nucl Cardiol"},{"key":"1529_CR56","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1007\/s12350-018-01547-1","volume":"27","author":"M St\u00e5hle","year":"2020","unstructured":"St\u00e5hle M, Kyt\u00f6 V, Kiugel M, Liljenb\u00e4ck H, Mets\u00e4l\u00e4 O, K\u00e4kel\u00e4 M, et al. Glucagon-like peptide-1 receptor expression after myocardial infarction: imaging study using 68Ga-NODAGA-exendin-4 positron emission tomography. J Nucl Cardiol. 2020;27:2386\u201397.","journal-title":"J Nucl Cardiol"},{"key":"1529_CR57","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11886-020-01372-4","volume":"22","author":"A \u0106orovi\u0107","year":"2020","unstructured":"\u0106orovi\u0107 A, Wall C, Mason JC, Rudd JHF, Tarkin JM. Novel positron emission tomography tracers for imaging vascular inflammation. Curr Cardiol Rep. 2020;22:119. https:\/\/doi.org\/10.1007\/s11886-020-01372-4.","journal-title":"Curr Cardiol Rep"},{"key":"1529_CR58","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","volume":"69","author":"JM Tarkin","year":"2017","unstructured":"Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV, et al. Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging. J Am Coll Cardiol. 2017;69:1774\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"1529_CR59","doi-asserted-by":"crossref","first-page":"e010389","DOI":"10.1161\/CIRCIMAGING.119.010389","volume":"13","author":"JM Tarkin","year":"2020","unstructured":"Tarkin JM, Wall C, Gopalan D, Aloj L, Manavaki R, Fryer TD, et al. Novel approach to imaging active Takayasu arteritis using somatostatin receptor positron emission tomography\/magnetic resonance imaging. Circ Cardiovasc Imaging. 2020;13:e010389.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1529_CR60","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1172\/JCI123859","volume":"129","author":"M Rieckmann","year":"2019","unstructured":"Rieckmann M, Delgobo M, Gaal C, B\u00fcchner L, Steinau P, Reshef D, et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest. 2019;129:4922\u201336.","journal-title":"J Clin Invest"},{"key":"1529_CR61","doi-asserted-by":"crossref","unstructured":"Wang Y, Dembowsky K, Chevalier E, St\u00fcve P, Korf-Klingebiel M, Lochner M, et al. C-X-C motif chemokine receptor 4 blockade promotes tissue repair after myocardial infarction by enhancing regulatory T cell mobilization and immune-regulatory function. Circulation. 2019;139:1798\u2013812.","DOI":"10.1161\/CIRCULATIONAHA.118.036053"},{"key":"1529_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","volume":"381","author":"M Husain","year":"2019","unstructured":"Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New Engl J Med. 2019;381:841\u201351.","journal-title":"New Engl J Med"},{"key":"1529_CR63","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s12350-019-01752-6","volume":"27","author":"A Autio","year":"2020","unstructured":"Autio A, Uotila S, Kiugel M, Kyt\u00f6 V, Liljenb\u00e4ck H, Kudomi N, et al. 68Ga-DOTA chelate, a novel imaging agent for assessment of myocardial perfusion and infarction detection in a rodent model. J Nucl Cardiol. 2020;27:891\u20138.","journal-title":"J Nucl Cardiol"},{"key":"1529_CR64","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00259-015-3111-9","volume":"42","author":"E Croteau","year":"2015","unstructured":"Croteau E, Renaud JM, McDonald M, Klein R, DaSilva JN, Beanlands RSB, et al. Test\u2013retest repeatability of myocardial blood flow and infarct size using 11C-acetate micro-PET imaging in mice. Eur J Nucl Med Mol Imaging. 2015;42:1589\u2013600.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1529_CR65","doi-asserted-by":"crossref","unstructured":"Borchert T, Hess A, Luka\u010devi\u0107 M, Ross TL, Bengel FM, Thackeray JT. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. Eur J Nucl Med Mol I. 2020;47(7):1757\u2013768.","DOI":"10.1007\/s00259-020-04736-8"},{"key":"1529_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4068\/cmj.2019.55.2.109","volume":"55","author":"H Park","year":"2019","unstructured":"Park H, Kim HS, Hong YJ, Min J-J, Kim HB, Kim MC, et al. Therapeutic effect of fimasartan in a rat model of myocardial infarction evaluated by cardiac positron emission tomography with [18F]FPTP. Chonnam Med J. 2019;55:109\u201315.","journal-title":"Chonnam Med J"},{"key":"1529_CR67","doi-asserted-by":"publisher","unstructured":"Li X, Yang W, Ma W, Zhou X, Quan Z, Li G, et al. 18F-FDG PET imaging-monitored anti-inflammatory therapy for acute myocardial infarction: Exploring the role of MCC950 in murine model. J Nucl Cardiol. 2020. https:\/\/doi.org\/10.1007\/s12350-020-02044-0.","DOI":"10.1007\/s12350-020-02044-0"},{"key":"1529_CR68","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2967\/jnumed.120.251900","volume":"61","author":"A Hess","year":"2020","unstructured":"Hess A, Borchert T, Langer BLN, Wester H, Ross T, Bengel F, et al. Multi-tracer molecular imaging reveals critical role of macrophages for cardiac repair after acute myocardial infarction. J Nucl Med. 2020;61:227 Available from: http:\/\/jnm.snmjournals.org\/content\/61\/supplement_1\/227.abstract.","journal-title":"J Nucl Med"},{"key":"1529_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12968-018-0454-y","volume":"20","author":"KP Kunze","year":"2018","unstructured":"Kunze KP, Dirschinger RJ, Kossmann H, Hanus F, Ibrahim T, Laugwitz K-L, et al. Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET\/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation. J Cardiovasc Magn Reson. 2018;20:33.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01529-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T07:55:47Z","timestamp":1672646147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01529-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01529-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"14 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This is a review article, which references papers that have used animal and\/or human participants in their studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"99"}}